$28.88
0.000.00%
Pre-Market: 4:00 PM EDT
Immunocore Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Immunocore Holdings using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-26 | $-0.47 | $-0.24 | -95.8 % |
Q3 | 2024-11-06 | $0.17 | $-0.34 | 150.0 % |
Q2 | 2024-08-08 | $-0.23 | $-0.47 | 51.1 % |
Q1 | 2024-05-08 | $-0.49 | $-0.36 | -36.1 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-26 | $84.05M | $83.55M | 0.60 % |
Q3 | 2024-11-06 | $80.25M | $79.12M | 1.43 % |
Q2 | 2024-08-08 | $75.40M | $74.72M | 0.91 % |
Q1 | 2024-05-08 | $70.50M | $71.15M | -0.91 % |
Immunocore Holdings (IMCR) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
The Actual EPS was $-0.47, which missed the estimate of $-0.24.
The Actual Revenue was $84.1M, which beat the estimate of $83.5M.
Browse earnings estimates, EPS, and revenue on all stocks.